The Saudi initiative for asthma

Annals of Thoracic Medicine

Volumn 4, Issue 4, 2009, Pages 216-233

  Al Moamary, Mohamed ^a,f   Al Hajjaj, Mohamed ^b   Idrees, Majdy ^c   Zeitouni, Mohamed ^d   Alanezi, Mohammed ^a   Al Jahdal, Hamdan ^a   Al Dabbagh, Maha ^e  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c The General Directorate of Armed Forces Health Services   (Saudi Arabia)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^e KING FAHD ARMED FORCES HOSPITAL   (Saudi Arabia)

^f NONE   (Saudi Arabia)

Author keywords

Asthma; Guidelines; Saudi Arabia

Indexed keywords

ACETYLSALICYLIC ACID; ALLERGEN; ANTIHISTAMINIC AGENT; BECLOMETASONE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CHOLINERGIC RECEPTOR BLOCKING AGENT; CICLESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; GLUCOCORTICOID; HYDROCORTISONE; IPRATROPIUM BROMIDE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; MAGNESIUM SULFATE; METHYLPREDNISOLONE; MONTELUKAST; NONSTEROID ANTIINFLAMMATORY AGENT; OMALIZUMAB; PREDNISOLONE; PREDNISONE; SALBUTAMOL; SALMETEROL; SHORT ACTING DRUG; THEOPHYLLINE; UNINDEXED DRUG;

ADD ON THERAPY; ADRENAL INSUFFICIENCY; ALLERGEN IMMUNOTHERAPY; ALLERGIC ASTHMA; ALLERGIC REACTION; ANAPHYLAXIS; ASTHMA; BITTER TASTE; CATARACT; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; DIABETES MELLITUS; DISEASE CONTROL; DISEASE EXACERBATION; DOCTOR PATIENT RELATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; DYSPHONIA; EVIDENCE BASED PRACTICE; EXERCISE INDUCED ASTHMA; FETUS DISEASE; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HEADACHE; HEALTH CARE ORGANIZATION; HEALTH CARE PERSONNEL; HEALTH CARE UTILIZATION; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPOKALEMIA; IMMUNOTHERAPY; INFLUENZA VACCINATION; INJECTION SITE CONTUSION; INJECTION SITE PAIN; LOW DRUG DOSE; MEDICAL LITERATURE; MUSCLE CRAMP; MUSCLE WEAKNESS; NAUSEA; OBESITY; OROPHARYNX CANDIDIASIS; OSTEOPOROSIS; PATHOPHYSIOLOGY; PATIENT EDUCATION; PRACTICE GUIDELINE; REVIEW; RISK FACTOR; RISK REDUCTION; SAUDI ARABIA; SAUDI INITIATIVE FOR ASTHMA; SEIZURE; SELF CARE; SIDE EFFECT; SINGLE DRUG DOSE; SKIN DISEASE; SKIN THINNING; TACHYCARDIA; THRUSH; TREATMENT OUTCOME; TREMOR; UNSPECIFIED SIDE EFFECT; VOMITING; XEROSTOMIA;

EID: 70349916353     PISSN: 18171737     EISSN: 19983557     Source Type: Journal    
DOI: 10.4103/1817-1737.56001     Document Type: Review

References (178)

1. Al Frayh AR, Shakoor Z, Gad El Rab MO, Hasnain SM. Increased prevalence of asthma in Saudi Arabia. Ann Allergy Asthma Immunol 2001;86:292-296 (Pubitemid 32240213)
2. Stewart W, Ricci J, Chee E, Morganstein D. Lost productive work time costs from health conditions in the United States: Results from the American productivity audit. J Occup Environ Med 2003;45:1234-1246 (Pubitemid 37541937)
3. Al-Mobeireek A. Prescribing for Asthmatic children in primary care: Are we following the guidelines? Saudi Med J 2003;24:1274.
4. Wechsler ME. Managing asthma in primary care: Putting new guideline recommendations into context. Mayo Clin Proc 2009;84:707-717
5. Global strategy for Asthma management and prevention. Global Initiative for Asthma (GINA). [updated in 2008]. Available from: http://www.ginAsthma.org. [last accessed on 2009 May 24].
6. Global strategy for Asthma management and prevention. Global Initiative for Asthma in children 5 years and younger. [updated in 2009 May]. Available from: http://www.ginAsthma.org. [last accessed on 2009 Jun 25].
7. Bousquet J, Clark TJ, Hurd S, Khaltaev N, Lenfant C, O'byrne P, et al. GINA guidelines on Asthma and beyond. Allergy 2007;62:102-112
8. National Asthma Education and Prevention Program, National Heart, Lung and Blood Institute, and National Institute of Health Guidelines for the Diagnosis and Management of Asthma. Asthma Expert Panel Report 2. Bethesda: National Institutes of Health; 1997. NIH 1: p. 97-4051. Available from: http://www.nhlbi.nih.gov. [last accessed on 2009 May 24].
9. Jadad AR, Moher M, Browman GP, Booker L, Sigouin C, Fuentes M, et al. Systematic reviews and meta-analyses on treatment of asthma: Critical evaluation. BMJ 2000;320:537-540 (Pubitemid 30175797)
10. Al-Ghamdi BR, Mahfouz AA, Abdelmoneim I, Khan MY, Daffallah AA. Altitude and bronchial Asthma in south-western Saudi Arabia. East Mediterr Health J 2008;14:17-23. (Pubitemid 351753088)
11. Al-Hajjaj M. Bronchial Asthma in developing countries: A major social and economic burden. Ann Thorac Med 2008;3:39-40.
12. Rabe F, Adachi M, Lai C, Soriano J, Vermeire P, Weiss K, et al. Worldwide severity and control of asthma in children and adults: The global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:40-47 (Pubitemid 39022491)
13. Abudahish A, Bella H. Primary care physicians perceptions and practices on asthma care in Aseer region, Saudi Arabia. Saudi Med J 2006;27:333-337
14. Alamoudi OS. Prevalence of respiratory diseases in hospitalized patients in Saudi Arabia: A 5 years study 1996-2000. Ann Thorac Med 2006;1:76-80.
15. Speight A, Lee D, Hey E. Underdiagnosis and undertreatment of asthma in childhood. Br Med J 1983;286:1253-1256
16. Al-Jahdali HH, Al-Hajjaj MS, Alanezi MO, Zeitoni MO, Al-Tasan TH. Asthma control assessment using Asthma control test among patients attending 5 tertiary care hospitals in Saudi Arabia. Saudi Med J 2008;29:714-717
17. Al Frayh AR. Asthma patterns in Saudi Arabian children. J R Soc Health 1990;110:98-100. (Pubitemid 20293767)
18. Al Frayh AR, Al Nahdi M, Bener AR, Jawadi TQ. Epidemiology of Asthma and allergic rhinitis in two coastal regions of Saudi Arabia. Allerg Immunol 1989;21:389-393 (Pubitemid 20077649)
19. Bener A, al-Jawadi TQ, Ozkaragoz F, Anderson JA. Prevalence of Asthma and wheeze in two different climatic areas of Saudi Arabia. Indian J Chest Dis Allied Sci 1993;35:9-15.
20. Hijazi N, Abalkhail B, Seaton A. Asthma and respiratory symptoms in urban and rural Saudi Arabia. Eur Respir J 1998;12:41-44 (Pubitemid 28325651)
21. Alshehri MA, Abolfotouh MA, Sadeg A, Al Najjar YM, Asindi AA, Al Harthi AM, et al. Screening for Asthma and associated risk factors among urban school boys in Abha city. Saudi Med J 2000;21:1048-1053 (Pubitemid 33694871)
22. Al-Kabbaa A, Al-Shamrani K, Salih MA. Does the management of bronchial asthma by family physicians meet standards of the national protocol? J Fam Comm Med 2002;9:21-25
23. Hamid Q, Tulic M. New insights into the pathophysiology of the small airways in Asthma. Ann Thorac Med 2007;2:28-33.
24. Cohn L, Homer R, Marinov A, Rankin J, Bottomly K. Induction of airway mucus production by T helper 2 (Th2) cells: A critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 1997;186:1737-1747 (Pubitemid 27506286)
25. Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergeninduced airway hyperreactivity. Nat Med 2003;9:582-588 (Pubitemid 36597105)
26. Alzoghaibi MA, BaHammam AS. Circulating LTB4 and Eotaxin-1 in stable asthmatics on inhaled corticosteroids and long-acting β 2-agonists. Ann Thorac Med 2006;1:67-70.
27. Humbert M, Corrigan C, Kimmitt P, Till S, Kay A, Durham S. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am J Respir Crit Care Med 1997;156:704-708 (Pubitemid 27396404)
28. Holgate S, Peters-Golden M, Panettieri R, Henderson W. Roles of cysteinyl leukotrienes in airway infl ammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003;111:S18-36. (Pubitemid 36135509)
29. Tobin M. Asthma, airway biology, and nasal disorders. Am J Respir Crit Care Med 2003;167:319-332
30. Linzer J. Review of asthma: Pathophysiology and current treatment options. Clin Pediatr Emerg Med 2007;8:87-95. (Pubitemid 47034857)
31. Kendrick A, Higgs C, Whitfi eld M, Laszlo G. Accuracy of perception of severity of asthma: Patients treated in general practice. Br Med J 1993;307:422-424
32. An S, Bai T, Bates J, Black J, Brown R, Brusasco V, et al. Airway smooth muscle dynamics: A common pathway of airway obstruction in asthma. Eur Respir J 2007;29:834-860 (Pubitemid 46722226)
33. Kinet J. The High-Affinity IgE receptor (FcεRI): From physiology to pathology. Annu Rev Immunol 1999;17:931-972 (Pubitemid 29241144)
34. James AL, Pare PD, Hogg JC. The mechanics of airway narrowing in asthma. Am Rev Respir Dis 1989;139:242-246
35. Hamid Q, Tulic MK. New insights into the pathophysiology of the small airways in asthma. Ann Thorac Med 2007;2:28-33.
36. Niimi A, Matsumoto H, Takemura M, Ueda T, Chin K, Mishima M. Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma. Am J Respir Crit Care Med 2003;168:983-988 (Pubitemid 37267177)
37. Stempel DA, McLaughin TP, Stanford RH, Fuhlbrigge AL. Patterns of asthma control: A 3-year analysis of patient claims. J Allergy Clin Immunol 2005;115:935-939
38. Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K, et al. Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 2007;7:8.
39. Kempel DA, McLaughin TP, Stanford RH, Fuhlbrigge AL. Patterns of asthma control: A 3-year analysis of patient claims. J Allergy Clin Immunol 2005;115:935-939
40. Berlow BA. Eight key questions to ask when your patient with asthma doesn't get better. Am Fam Physician 1997;55:183-89,192-194
41. Fireman P. Rhinitis and asthma connection: Management of coexisting upper airway allergic diseases and asthma. Allergy Asthma Proc 2000;21:45-54.
42. Al-Mobeireek AF, Al-Sarhani A, Al-Amri S, Bamgboye E, Ahmed SS. Chronic cough at a nonteaching hospital: Are extrapulmonary causes overlooked? Respirology 2002;7:141-146
43. Al-Otair H, BaHammam A. Unusual cause of respiratory distress misdiagnosed as refractory asthma. Ann Thorac Med 2006;1:28-30. (Pubitemid 44271813)
44. Cowie RL, Underwood MF, Field SK. Asthma symptoms do not predict spirometry. Can Respir J 2007;14:339-342
45. Tashkin DP, Altose MD, Connett JE, Kanner RE, Lee WW, Wise RA. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996;153:1802-1811
46. Witteman A, Stapel S, Perdok G, Sjamsoedin D, Jansen H, Aalberse R, et al. The relationship between RAST and skin test results in patients with asthma or rhinitis: A quantitative study with purifi ed major allergens. J Allergy Clin Immunol 1996;97:16-25. (Pubitemid 26045964)
47. Doherty G, Bush A. Diagnosing respiratory problems in young children. Practitioner 2007;251:20,22-25
48. Pedersen S. Preschool asthma - not so easy to diagnose. Prim Care Respir J 2007;16:4-6. (Pubitemid 46364349)
49. Townshend J, Hails S, Mckean M. Diagnosis of asthma in children. BMJ 2007;335:198-202.
50. Sly PD, Boner AL, Bjorksten B, Bush A, Custovic A, Eigenmann PA, et al. Early identifi cation of atopy in the prediction of persistent asthma in children. Lancet 2008;372:1100-1106
51. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the fi rst six years of life: The Group Health Medical Associates. N Engl J Med 1995;332:133-138
52. Martinez F, Wright A, Taussig L, Holberg C, Halonen M, Morgan W, et al. Asthma and wheezing in the fi rst six years of life. N Engl J Med 1995;332:133-138
53. Gelfand E. Pediatric asthma: A different disease. Proc Am Thorac Soc 2009;6:278-282
54. Moore W. Update in Asthma 2008. Am J Respir Crit Care Med 2009;179:869-874
55. Moore WC, Peters SP. Update in Asthma 2006. Am J Respir Crit Care Med 2007;175:649-654
56. Brand P, Baraldi E, Bisgaard H, Boner A, Castro-Rodriguez J, Custovic A, et al. Defi nition, assessment and treatment of wheezing disorders in preschool children: An evidence-based approach. Eur Respir J 2008;32:1096-1110
57. Creticos PS. Treatment options for initial maintenance therapy of persistent Asthma: A review of inhaled corticosteroids and leukotriene receptor antagonists. Drugs 2003;63:1-20. (Pubitemid 37421785)
58. Lemanske RF Jr, Sorkness CA, Mauger EA, Lazarus SC, Boushey HA, Fahy JV, et al. Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol. JAMA 2001;285:2594-2603
59. Pauwels RA, Pedersen S, Busse WW, Tan WC, Chen YZ, Ohlsson SV, et al. Early intervention with budesonide in mild persistent asthma: A randomised, double-blind trial. Lancet 2003;361:1071-1076 (Pubitemid 36369558)
60. Barnes P, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993;148:S1-26. (Pubitemid 23301241)
61. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994;331:700-705 (Pubitemid 24275742)
62. Rohatagi S, Appajosyula S, Derendorf H, Szefl er S, Nave R, Zech K, et al. Risk-benefi t value of inhaled glucocorticoids: A pharmacokinetic/ pharmacodynamic perspective. J Pharmacokinet Pharmacodyn 2004;44:37-47.
63. Kelly H. Comparison of inhaled corticosteroids: An update. Ann Pharmacother 2009;43:519-527
64. Drake AJ, Howells RJ, Shield JP, Prendiville A, Ward PS, Crowne EC. Symptomatic adrenal insuffi ciency presenting with hypoglycaemia in asthmatic children with asthma receiving high dose inhaled fl uticasone propionate. Br Med J 2002;324:1081-1083 (Pubitemid 34492819)
65. Lazarus S, Chinchilli V, Rollings N, Boushey H, Cherniack R, Timothy J, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007;175:783-790 (Pubitemid 46631789)
66. Fish J, Ford J, Israel E, Kiley J, Kraft M. Signifi cant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109:410-418 (Pubitemid 34234189)
67. Masoli M, Weatherall M, Holt S, Beasley R. Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. Thorax 2005;60:730-734 (Pubitemid 41297891)
68. Boehmer A, Merkus P. Asthma therapy for children under 5 years of age. Curr Opin Pulm Med 2006;12:34-42. (Pubitemid 44378576)
69. Brand P, Baraldi E, Bisgaard H, Boner A, Castro-Rodriguez J, Custovic A, et al. Defi nition, assessment and treatment of wheezing disorders in preschool children: An evidence-based approach. Eur Respir J 2008;32:1096-1110
70. Dubus J, Marguet C, Deschildre A, Mely L, Le Roux P, Brouard J, et al. Local side-effects of inhaled corticosteroids in asthmatic children: Infl uence of drug, dose, age, and device. Allergy 2001;56:944-948
71. Toogood J. Side effects of inhaled corticosteroids. J Allergy Clin Immunol 1998;102:705-713
72. Lipworth B, Kaliner M, LaForce C, Baker J, Kaiser H, Amin D, et al. Effect of ciclesonide and fl uticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma. Ann Allergy Asthma Immunol 2005.94:465-472 (Pubitemid 40547935)
73. Szefl er S, Rohatagi S, Williams J, Lloyd M, Kundu S, Banerji D. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary- adrenal axis function in patients with moderate-to-severe persistent asthma. Chest 2005;:1104-1114
74. Lazarus S, Boushey H, Fahy J, Chinchilli V, Lemanske R, Sorkness C, et al. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: A randomized controlled trial. JAMA 2001;285:2583-2593 (Pubitemid 32479898)
75. Wenzel S, Lumry W, Manning M, Kalberg C, Cox F, Emmett A, et al. Effi cacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma. Ann Allergy Asthma Immunol 1998;80:463-470 (Pubitemid 28285669)
76. Malone R, LaForce C, Nimmagadda S, Schoaf L, House K, Ellsworth A, et al. The safety of twice-daily treatment with fl uticasone propionate and salmeterol in pediatric patients with persistent asthma. Ann Allergy Asthma Immunol 2005;95:66-71. (Pubitemid 41022775)
77. Palmqvist M, Persson G, Lazer L, Rosenborg J, Larsson P, Lotvall J. Inhaled dry-powder formoterol and salmeterol in asthmatic patients: Onset of action, duration of effect and potency. Eur Respir J 1997;10:2484-2489 (Pubitemid 28048620)
78. O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication. Am J Respir Crit Care Med 2005;171:129-136 (Pubitemid 40105411)
79. Ferrari M, Segattini C, Zanon R, Bertaiola M, Balestreri F, Brotto E, et al. Comparison of the protective effect of formoterol and of salmeterol against exercise-induced bronchospasm when given immediately before a cycloergometric test. Respiration 2002;69:509-512 (Pubitemid 35404293)
80. Bisgaard H. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children. Pediatr Pulmonol 2003;36:391-398 (Pubitemid 37296699)
81. Palmqvist M, Ibsen T, Mellén A, Lötvall J. Comparison of the relative effi cacy of formoterol and salmeterol in asthmatic patients. Am J Respir Crit Care Med 1999;160:244-249 (Pubitemid 29326095)
82. Currie G, Lipworth B. Bronchoprotective effects of leukotriene receptor antagonists in Asthma: A meta-analysis. Chest 2002;122:146-150 (Pubitemid 34754154)
83. Leff J, Busse W, Pearlman D, Bronsky E, Kemp J, Hendeles L, et al. Montelukast: A leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 1998;339:147-152 (Pubitemid 28328478)
84. Bjermer L, Diamant Z. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in Asthma. Monaldi Arch Chest Dis 2002;57:76-83. (Pubitemid 34873745)
85. Idrees M, Al-Moamary M. Blocking leukotrienes optimize Asthma control: The BLOC survey. Ann Thorac Med 2007;2:99-102. (Pubitemid 47220037)
86. Barnes P. Theophylline: New perspectives for an old drug. Am J Respir Crit Care Med 2003;167:813-818 (Pubitemid 36801766)
87. Green R, Brightling C, Pavord I, Wardlaw A. Management of asthma in adults: Current therapy and future directions. Postgrad Med J 2003;79:259-267 (Pubitemid 36724234)
88. Barnes P, Adcock I. Steroid resistance in asthma. Q J Med 1995;88:455-468
89. Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Cioppa GD, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic Asthma. J Allergy Clin Immunol 2001;108:184-190 (Pubitemid 32735398)
90. Prenner BM. Asthma 2008: Targeting immunoglobulin E to achieve disease control. J Asthma 2008;45:429-436
91. Mash B, Bheekie A, Jones PW. Inhaled vs oral steroids for adults with chronic asthma. Cochrane Database Syst Rev 2001;1:CD002160.
92. Peat I, Healy S, Reid D, Ralston S. Steroid induced osteoporosis: An opportunity for prevention? Ann Rheum Dis 1995;54:66-68
93. Waldeck B. Enantiomers of bronchodilating beta2-adrenoceptor agonists: Is there a cause for concern? J Allergy Clin Immunol 1999;103:742-748
94. Berger WE. Levalbuterol: Pharmacologic properties and use in the treatment of pediatric and adult asthma. Ann Allergy Asthma Immunol 2003;90:583-591 (Pubitemid 36712662)
95. Gibson P, Powell H, Coughlan J, Wilson A, Abramson M, Haywood P, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003;1:CD001117.
96. 2-agonists in the treatment of asthma. N Engl J Med 1996;335:886-888
97. Rodrigo G, Rodrigo C, Burschtin O. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am J Med 1999;107:363-370 (Pubitemid 29465815)
98. Al-Jahdali HH, Al-Zahrani AI, Al-Otaibi ST, Hassan IS, Al-Moamary MS, Al-Duhaim AS, et al. Perception of the role of inhaled corticosteroids and factors affecting compliance among Asthmatic adult patients. Saudi Med J 2007;28:569-573
99. Alsheri MA. Comparative study of different inhaler devices in Asthmatic children. Ann Saudi Med 2003; 23:349-353
100. Al-Wasil MA, Al-Mohaimeed A. Assessment of inhalation technique in primary care Asthmatic patients using metered-dose inhalers with or without a spacer. Ann Saudi Med 2003;23:264-269 (Pubitemid 37259299)
101. AL-Haddad N, Nour A, Koshak E. Asthma care: Structural foundations at primary health care at Al-Qassim region, Saudi Arabia. Ann Thorac Med 2006;1:8-11. (Pubitemid 44271808)
102. Al-Moamary. Unconventional therapy use among Asthma patients in a tertiary care center in Riyadh, Saudi Arabia. Ann Thorac Med 2008;3:48-51.
103. Al-Haddad N, Al-Ansari SS, Al-Shari AT. Impact of Asthma education program on Asthma knowledge of general practitioners. Ann Saudi Med 1997;17:550-552 (Pubitemid 28182073)
104. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defi ned Asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med 2004;170:836-844 (Pubitemid 39346477)
105. Al-Shimemeri A, Al-Ghadeer H, Giridhar H, Al-Jahdali M, Al-Moamary M, Khan J, et al. Impact of an extensive Asthma education campaign for physicians on their drug prescription practices. Ann Thorac Med 2006;1:20-25 (Pubitemid 44271811)
106. Alamoudi OS. The efficacy of a management protocol in reducing emergency visits and hospitallizations in chronic Asthmatics. Saudi Med J 2002;23:1373-1379
107. Al-Jahdali HH, Al-Omar AM, Al-Moamary MS, Al-Duhaim AS, Al-Hodeib AS, Hassan IS, et al. Implementation of the national Asthma management guidelines in the emergency department. Saudi Med J 2004;25:1208-1211 (Pubitemid 39334950)
108. Buist A, Vollmer W, Wilson S, Frazier E, Hayward A. A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma. Am J Respir Crit Care Med 2006;174:1077-1087 (Pubitemid 44772077)
109. Al-Frayh AS, Hasnain SM, Gad-El-Rab MO, Schwartz B, Al-Mobairek K, Al-Sedairy ST. House dust mite allergens in Saudi Arabia: Regional variations and immune response. Ann Saudi Med 1997;17:156-160 (Pubitemid 27405977)
110. Hasnain SM, Fatima K, Al-Frayh A. Prevalence of airborne allergenic Amaranthus viridis pollen in seven different regions of Saudi Arabia. Ann Saudi Med 2007;27:259-263 (Pubitemid 47527592)
111. Troisi RJ, Speizer FE, Rosner B, Trichopoulos D, Willett WC. Cigarette smoking and incidence of chronic bronchitis and asthma in women. Chest 1995;108:1557-1561
112. Tunnicliffe WS, Fletcher TJ, Hammond K, Roberts K, Custovic A, Simpson A, et al. Sensitivity and exposure to indoor allergens in adults with differing asthma severity. Eur Respir J 1999;13:654-659 (Pubitemid 29180181)
113. Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, Wiselka MJ, Leese J, Ayres J, et al. Randomised placebo-controlled crossover trial on effect of inactivated infl uenza vaccine on pulmonary function in asthma. Lancet 1998;351:326-331 (Pubitemid 28052698)
114. Humbert M, Holgate S, Boulet LP, Bousquet J. Asthma control or severity: That is the question. Allergy 2007;62:95-101. (Pubitemid 46090289)
115. Koshak E. Classifi cation of Asthma according to revised 2006 GINA: Evolution from severity to control. Ann Thorac Med 2007;2:45-46
116. Lababidi H, Hijaoui A, Zarzour M. Validation of the Arabic version of the Asthma control test. Ann Thorac Med 2008;3:44-47
117. Alanezi M, Al-Jahdali HH, Al-Hajjaj MS, Zeitoni MO, Al-Tasan TH. Levels of acceptance of Asthma Control Test questionnaire among Saudi patients attending 5 tertiary care hospitals in Saudi Arabia. Saudi Med J 2009;30:546-549
118. Ignacio-Garcia JM, Gonzalez-Santos P. Asthma self-management education program by home monitoring of peak expiratory fl ow. Am J Respir Crit Care Med 1995;151:353-359
119. Hawkins G, McMahon AD, Twaddle S, Wood SF, Ford I, Thomson NC. Stepping down inhaled corticosteroids in asthma: Randomised controlled trial. BMJ 2003;326:1115. (Pubitemid 36613440)
120. Boulet LP, Drollmann A, Magyar P, Timar M, Knight A, Engelstatter R, et al. Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma. Respir Med 2006;100:785-794
121. Bateman ED, Fairall L, Lombardi DM, English R. Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. Respir Res 2006;7:13. (Pubitemid 43316137)
122. Masoli M, Weatherall M, Holt S, Beasley R. Budesonide once versus twice-daily administration: Meta-analysis. Respirology 2004;9:528-534 (Pubitemid 40179760)
123. Randell TL, Donaghue KC, Ambler GR, Cowell CT, Fitzgerald DA, van Asperen PP. Safety of the newer inhaled corticosteroids in childhood asthma. Paediatr Drugs 2003;5:481-504. (Pubitemid 36976118)
124. Powell H, Gibson PG. Initial starting dose of inhaled corticosteroids in adults with asthma: A systematic review. Thorax 2004;59:1041-1045 (Pubitemid 39573922)
125. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999;340:197-206. (Pubitemid 29063217)
126. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, et al. Low dose inhaled budesonide and formoterol in mild persistent Asthma: The OPTIMA randomized trial. Am J Respir Crit Care Med 2001;164:1392-1397 (Pubitemid 33124016)
127. Godard P, Greillier P, Pigearias B, Nachbaur G, Desfougeres JL, Attali V. Maintaining Asthma control in persistent Asthma: Comparison of three strategies in a 6-month double-blind randomised study. Respir Med 2008;102:1124-1131
128. Kankaanranta H, Lahdensuo A, Moilanen E, Barnes PJ. Addon therapy options in Asthma not adequately controlled by inhaled corticosteroids: A comprehensive review. Respir Res 2004;5:17. (Pubitemid 41363578)
129. Lundborg M, Wille S, Bjermer L, Tilling B, Lundgren M, Telg G, et al. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in Asthma: An effi cacy and cost-effectiveness study. Curr Med Res Opin 2006;22:809-821 (Pubitemid 43875550)
130. O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in Asthma. Am J Respir Crit Care Med 2005;171:129-136 (Pubitemid 40105411)
131. Szefl er SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Signifi cant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109:410-418
132. Powell H, Gibson PG. Inhaled corticosteroid doses in asthma: An evidence-based approach. Med J Aust 2003;178:223-225 (Pubitemid 36329216)
133. Vaqueriz OM, Casan P, Castillo J, Perpiña M, Sanchis J, Sobradillo V, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma. Thorax 2003;58:204-210 (Pubitemid 36307997)
134. Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, et al. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: A systematic review. Thorax 2008;63:453-462 (Pubitemid 351698876)
135. Zeiger RS, Szefl er SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, et al. Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood Asthma. J Allergy Clin Immunol 2006;117:45-52.
136. Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med 1997;337:1412-1418 (Pubitemid 27497888)
137. Bateman E, Bousquet J, Keech M, Busse W, Clark T, Pedersen S. The correlation between asthma control and health status: the GOAL study. Eur Respir J 2007;29:56-62. (Pubitemid 46091998)
138. Pauwels RA, Lofdahl CG, Postma DS, Tattersfi eld AE, O'Byrne, P, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma: Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-1411
139. Pauwels RA, Lofdahl CG, Postma DS, Tattersfi eld AE, O'Byrne P, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma: Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997;337:1405-1411
140. Castro-Rodriguez JA, Rodrigo GJ. Beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: A systematic review with meta-analysis. J Pediatr 2004;145:172-177
141. Cates CJ, Crilly JA, Rowe BH. Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2006:CD000052.
142. Deerojanawong J, Manuyakorn W, Prapphal N, Harnruthakorn C, Sritippayawan S, Samransamruajkit R. Randomized controlled trial of salbutamol aerosol therapy via metered dose inhaler-spacer vs. jet nebulizer in young children with wheezing. Pediatr Pulmonol 2005;39:466-472 (Pubitemid 40548291)
143. Castro-Rodriguez J, Rodrigo J. Effi cacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: A systematic review with meta-analysis. Pediatrics 2009;123:e519-25.
144. Hakim F, Vilozni D, Adler A, Livnat G, Tal A, Bentur L. The effect of montelukast on bronchial hyperreactivity in preschool children. Chest 2007;131:180-186 (Pubitemid 46122990)
145. Bisgaard H, Nielsen KG. Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. Am J Respir Crit Care Med 2000;162:187-190 (Pubitemid 30469818)
146. Bisgaard H, Gillies J, Groenewald M, Maden C. The effect of inhaled fl uticasone propionate in the treatment of young asthmatic children: A dose comparison study. Am J Respir Crit Care Med 1999;160:126-131 (Pubitemid 29326077)
147. Bousquet J, Lockey RF, Malling HJ. WHO position paper: Allergen immunotherapy: Therapeutic vaccines for allergic diseases. Allergy 1998;53:1-42. (Pubitemid 28346358)
148. Join Task Force on Practice Parameters. Allergen immunotherapy: A practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 2003;90:1-40.
149. Namazy J, Schatz M, Pregnancy and asthma: Recent developments. Curr Opin Pulm Med 2005;11:56-60.
150. Schatz M, Harden K, Forsythe A, Chilingar L, Hoffman C, Sperling W, et al. The course of asthma during pregnancy, post partum, and with successive pregnancies: A prospective analysis. J Allergy Clin Immunol 1988;81:509-517 (Pubitemid 18089929)
151. Murphy VE, Gibson PG, Smith R, Clifton VL. Asthma during pregnancy: Mechanisms and treatment implications. Eur Respir J 2005;25:731-750 (Pubitemid 40528770)
152. Hanania N, Michael B. Acute asthma in pregnancy: Scientifi c Reviews. Crit Care Med 2005;:S319-24.
153. Rahimi R, Nikfar S, Abdollahi M. Meta-analysis fi nds use of inhaled corticosteroids during pregnancy safe: A systematic meta-analysis review. Hum Exp Toxicol 2006;25:447-452 (Pubitemid 44384586)
154. Dicpinigaitis PV. Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines. Chest 2006;129:75S-9S.
155. Morice AH, McGarvey L, Pavord I; on behalf of the British Thoracic Society Cough GU. Recommendations for the management of cough in adults. Thorax 2006;61:i1-24.
156. Sears M, Lötvall J. Past, present and future-beta2-adrenoceptor agonists in asthma management. Respir Med 2005;99:152-170 (Pubitemid 40104270)
157. Benedictis F, del Giudice M, Forenza N, Decimo F, de Benedictis D, Capristo A. Lack of tolerance to the protective effect of montelukast in exercise-induced bronchoconstriction in children. Eur Respir J 2006;28:291-295 (Pubitemid 44914226)
158. Joos S, Miksch A, Szecsenyi J, Wieseler B, Grouven U, Kaiser T, et al. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: A systematic review. Thorax 2008;63:453-462 (Pubitemid 351698876)
159. Szczeklik A, Stevenson DD. Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111:913-921 (Pubitemid 36570845)
160. Stevenson DD. Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-infl ammatory drugs. J Allergy Clin Immunol 1984;74:617-622
161. Al-Asoom LI, Al-Rubaish A, Al-Quorain AA, Qutub H, El- Munshid HA. The association of gastroesophageal reflux with bronchial Asthma: Can Asthma also trigger reflux? Hepatogastroenterology 2006;53:64-72.
162. Gaude G. Pulmonary manifestations of gastroesophageal refl ux disease. Ann Thorac Med 2009;4:115-123
163. Asano K, Suzuki H. Silent acid refl ux and asthma control. N Engl J Med 2009;360:1551-1553
164. Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet 1999;353:364-369 (Pubitemid 29088164)
165. Al-Dawood KM. Pattern and risk factors associated with hospital emergency visits among schoolboys with bronchial Asthma in Al-Khobar. Ann Saudi Med 2002;22:29-33. (Pubitemid 34919016)
166. Courtney A, Mccarter D, Pollart S. Childhood asthma: Treatment update. Am Fam Physician 2005;71:1959-1968
167. Cates CC, Bara A, Crilly JA, Rowe BH. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev 2003;3:CD000052.
168. Abu-Ekteish FM, Zahraa JN, Al-Mobaireek KF, Nasir AA, Al-Frayh AS. The management of acute severe Asthma in a pediatric intensive care unit. Saudi Med J 2003;24:388-390 (Pubitemid 36626088)
169. Rodrigo GJ, Rodrigo C. The role of anticholinergics in acute asthma treatment: An evidence-based evaluation. Chest 2002;121:1977-1987 (Pubitemid 34634423)
170. Plotnick LH, Ducharme FM. Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children. Cochrane Database Syst Rev 2004;4:CD000060.
171. Qureshi F, Zaritsky A, Lakkis H. Efficacy of nebulized ipratropium in severely asthmatic children. Ann Emerg Med 1997;29:205-211 (Pubitemid 27053562)
172. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. Cochrane Database Syst Rev 2004;4:CD002178.
173. Ducharme FM, Chabot G, Polychronakos C, Glorieux F, Mazer B. Safety profi le of frequent short courses of oral glucocorticoids in acute pediatric asthma: Impact on bone metabolism, bone density, and adrenal function. Pediatrics 2003;111:376-383 (Pubitemid 36177159)
174. Smith M, Iqbal S, Elliott TM, Rowe BH. Corticosteroids for hospitalised children with acute asthma. Cochrane Database Syst Rev 2004;4:CD002886.
175. Rowe BH, Bretzlaff JA, Bourdon C, Bota GW, Camargo CA Jr. Magnesium sulfate for treating exacerbations of acute asthma in the emergency department. Cochrane Database Syst Rev 2000;2.
176. FitzGerald JM. Magnesium sulfate is effective for severe acute asthma treated in the emergency department. West J Med 2000;172:96.
177. Parameswaran K, Belda J, Rowe B, Lynch. Addition of intravenous aminophylline to beta2-agonist in adults with acute asthma. Cochrane Database syst Rev 2000;4: Art. No.: CD002742.
178. Alzeer A, BaHammam A, Masood M, Basha SJ, Alhamad E, Sohail S. Outcome of patients with severe Asthma in the intensive care unit. Ann Saudi Med 2006;26:461-465